SynthesisTargeted oncology2025

Efficacy and Safety of Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Studies.

Hui-Chen Su et al.PubMed ↗Publisher ↗

No numbers read from the abstract.